Signal active
Investment Firm
Overview
Piper Jaffray Merchant Banking (PJMB) is a part of the asset management business of Piper Jaffray Companies (NYSE: PJC) and operates as the private equity arm of the firm. PJMB is supported by Piper Jaffray capital and that of distinguished non-affiliated limited partners. The group seeks investments in private, commercial stage businesses with strong growth prospects within the industry sectors covered by Piper Jaffray equity research and investment banking resources. Revenue is ranging from 275M to 500M.
Highlights
1895
0
9
7
4
Late Stage Venture, Early Stage Venture
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
Piper Jaffray Merchant Banking, established in 1895 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Software, Internet, Shopping, Health Care, Wellness, Financial Services, Venture Capital, Finance, FinTech, Banking. The organization boasts a portfolio of 9 investments, with an average round size of $26.4M and 4 successful exits. Their recent investments include Sapphire Digital, Activate Venture Partners, Greycroft, Cardinal Partners, Health Enterprise Partners. The highest investment round they participated in was $11.3B. Among their most notable exits are Sapphire Digital and Activate Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
9
1
7
4
Investments
9
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Dec 05, 2019 | - | - | 50.0M |
Aug 14, 2020 | Paragon 28 | Hardware | null |
Jun 01, 2022 | Moxe Health | Health Care | 30.0M |
Apr 30, 2024 | Integrity Orthopaedics | Health Care | 20.6M |
Exits
4
Funding Timeline
9
0
1
Funding Rounds
9
Piper Jaffray Merchant Banking has raised 9 rounds. Their latest funding was raised on Apr 30, 2024 from a Series B - Integrity Orthopaedics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Dec 05, 2019 | Series D - Akoya Biosciences | - | 50.0M | - |
Aug 14, 2020 | Series B - Paragon 28 | - | 0 | - |
Jun 01, 2022 | Series B - Moxe Health | - | 30.0M | - |
Apr 30, 2024 | Series B - Integrity Orthopaedics | - | 20.6M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.